Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1303533-78-9

C41H42N6O4 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1303533-78-9 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1303533-78-9 Structure

  • Basic information

    1. Product Name: C41H42N6O4
    2. Synonyms: C41H42N6O4
    3. CAS NO:1303533-78-9
    4. Molecular Formula:
    5. Molecular Weight: 682.822
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1303533-78-9.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: C41H42N6O4(CAS DataBase Reference)
    10. NIST Chemistry Reference: C41H42N6O4(1303533-78-9)
    11. EPA Substance Registry System: C41H42N6O4(1303533-78-9)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1303533-78-9(Hazardous Substances Data)

1303533-78-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1303533-78-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,0,3,5,3 and 3 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1303533-78:
(9*1)+(8*3)+(7*0)+(6*3)+(5*5)+(4*3)+(3*3)+(2*7)+(1*8)=119
119 % 10 = 9
So 1303533-78-9 is a valid CAS Registry Number.

1303533-78-9Downstream Products

1303533-78-9Relevant articles and documents

BENZIMIDAZOLE-IMIDAZOLE DERIVATIVES

-

, (2011/06/11)

Inhibitors of HCV replication of formula (I) including stereochemically isomeric forms, and salts, solvates thereof, wherein R and R' are, each independently,-CR1R2R3, aryl, heteroaryl or heteroC4-6cycloalkyl, whereby aryl and heteroaryl may optionally be substituted with 1 or 2 substituents selected from halo and methyl. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use in HCV therapy.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1303533-78-9